Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Daniel Voth

TitleDepartment Chairperson
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentDepartment Chairs, College of Medicine
Address506F Biomedical Research I
325 S. Elm St.
Mail Slot # 511
Little Rock AR 72205
Phone501-686-8050
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    1R21AI173725-01A1     (VOTH, DANIEL)Jun 10, 2024 - Apr 30, 2026
    NIH/Nat. Inst. of Allergy & Infectious Diseases
    Defining Coxiella burnetii Infection of Primary Human Cardiac Cells
    Role: Principal Investigator
    5R21AI173725-02     (VOTH, DANIEL)Jun 10, 2024 - Apr 30, 2026
    NIH/Nat. Inst. of Allergy & Infectious Diseases
    Defining Coxiella burnetii Infection of Primary Human Cardiac Cells
    Role: Principal Investigator
    R21AI173725     (VOTH, DANIEL E)Jun 10, 2024 - Apr 30, 2026
    NIH
    Defining the impact of host-directed drugs on Coxiella burnetii growth in macrophages
    Role: Principal Investigator
    -     (VOTH, DANIEL)Dec 15, 2023 - Dec 14, 2024
    UAMS Internal Research Awards
    Defining the impact of host-directed drugs on Coxiella burnetii growth in macrophages
    Role: Principal Investigator
    C06OD032002     (VOTH, DANIEL)Sep 19, 2022 - May 31, 2027
    NIH/Office of the Director
    Expanding UAMS Research Capacity to Investigate the Host Response to Infectious Disease
    Role: Principal Investigator
    R21AI144508     (VOTH, DANIEL E)Sep 1, 2020 - Aug 31, 2022
    NIH
    Coxiella burnetii Subversion of Host Nrf2 Antioxidant Signaling- Resubmission
    Role: Principal Investigator
    R21AI142056     (VOTH, DANIEL E)Nov 19, 2018 - Oct 31, 2021
    NIH
    A Novel Human Lung Infection Platform to Define Staphylococcus aureus Virulence Determinants
    Role: Principal Investigator
    R21AI127931     (VOTH, DANIEL E)May 25, 2017 - Apr 30, 2020
    NIH
    Characterization of the Human Lung Response to Coxiella burnetii
    Role: Principal Investigator
    R21AI107148     (VOTH, DANIEL E)May 10, 2013 - Apr 30, 2017
    NIH
    Coxiella burnetii Regulation of Macrophage cAMP/PKA Signaling
    Role: Principal Investigator
    R01AI087669     (VOTH, DANIEL E)Jul 1, 2010 - Jun 30, 2017
    NIH
    Role of the Coxiella burnetii Cryptic Plasmid in Host Cell Parasitism
    Role: Principal Investigator
    10BGIA3080001     (VOTH, DANIEL)Jul 1, 2010 - Jun 30, 2012
    American Heart Association (South Central Affiliate)
    Manipulation of host signaling by the Q fever agent, Coxiella burnetii
    Role: Principal Investigator
    K22AI081753     (VOTH, DANIEL E)Apr 15, 2009 - Mar 31, 2011
    NIH
    Functional Characterization of Coxiella burnetii Dot/Icm Substrates
    Role: Principal Investigator
    R01GM061019     (VOTH, DANIEL E)Mar 1, 2000 - Dec 31, 2021
    NIH
    Bacterial cell wall synthesis, shape and septation
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Marena Guzman R, Voth DE. Embracing multiple infection models to tackle Q fever: A review of in vitro, in vivo, and lung ex vivo models. Cell Immunol. 2024 Nov-Dec; 405-406:104880. PMID: 39357100.
      View in: PubMed
    2. Jackson-Litteken CD, Guo W, Hogland BA, Ratliff CT, McFadden L, Fullerton MS, Voth DE, Rego ROM, Blevins JS. Development and validation of systems for genetic manipulation of the Old World tick-borne relapsing fever spirochete, Borrelia duttonii. PLoS Negl Trop Dis. 2024 Jul; 18(7):e0012348. PMID: 39038047.
      View in: PubMed
    3. Sachan M, Brann KR, Fullerton MS, Voth DE, Raghavan R. MicroRNAs Contribute to Host Response to Coxiella burnetii. Infect Immun. 2023 01 24; 91(1):e0019922. PMID: 36537791.
      View in: PubMed
    4. Sim?es I, Voth DE, Mota LJ. Editorial: Obligate intracellular bacteria: Evasion and adaptative tactics shaping the host-pathogen interface. Front Cell Infect Microbiol. 2022; 12:965554. PMID: 35909957.
      View in: PubMed
    5. Andrews JT, Voth DE, Huang SC, Huang L. Breathe In, Breathe Out: Metabolic Regulation of Lung Macrophages in Host Defense Against Bacterial Infection. Front Cell Infect Microbiol. 2022; 12:934460. PMID: 35899042.
      View in: PubMed
    6. Fullerton MS, Colonne PM, Dragan AL, Brann KR, Kurten RC, Voth DE. Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells. mSphere. 2021 08 25; 6(4):e0044221. PMID: 34232075.
      View in: PubMed
    7. Dragan AL, Voth DE. Take my breath away: studying pathogen invasion of the human lung using primary tissue models. Pathog Dis. 2021 03 31; 79(4). PMID: 33734371.
      View in: PubMed
    8. Brann KR, Fullerton MS, Voth DE. Coxiella burnetii Requires Host Eukaryotic Initiation Factor 2a Activity for Efficient Intracellular Replication. Infect Immun. 2020 06 22; 88(7). PMID: 32284364.
      View in: PubMed
    9. Dragan AL, Voth DE. Coxiella burnetii: international pathogen of mystery. Microbes Infect. 2020 04; 22(3):100-110. PMID: 31574310.
      View in: PubMed
    10. Brann KR, Fullerton MS, Onyilagha FI, Prince AA, Kurten RC, Rom JS, Blevins JS, Smeltzer MS, Voth DE. Infection of Primary Human Alveolar Macrophages Alters Staphylococcus aureus Toxin Production and Activity. Infect Immun. 2019 07; 87(7). PMID: 31010814.
      View in: PubMed
    11. Dragan AL, Kurten RC, Voth DE. Characterization of Early Stages of Human Alveolar Infection by the Q Fever Agent Coxiella burnetii. Infect Immun. 2019 03; 87(5). PMID: 30833339.
      View in: PubMed
    12. Cockburn CL, Green RS, Damle SR, Martin RK, Ghahrai NN, Colonne PM, Fullerton MS, Conrad DH, Chalfant CE, Voth DE, Rucks EA, Gilk SD, Carlyon JA. Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens. Life Sci Alliance. 2019 04; 2(2). PMID: 30902833.
      View in: PubMed
    13. Shaw EI, Voth DE. Coxiella burnetii: A Pathogenic Intracellular Acidophile. Microbiology (Reading). 2019 01; 165(1):1-3. PMID: 30422108.
      View in: PubMed
    14. Winchell CG, Dragan AL, Brann KR, Onyilagha FI, Kurten RC, Voth DE. Coxiella burnetii Subverts p62/Sequestosome 1 and Activates Nrf2 Signaling in Human Macrophages. Infect Immun. 2018 05; 86(5). PMID: 29483292.
      View in: PubMed
    15. Mahapatra S, Gallaher B, Smith SC, Graham JG, Voth DE, Shaw EI. Coxiella burnetii Employs the Dot/Icm Type IV Secretion System to Modulate Host NF-?B/RelA Activation. Front Cell Infect Microbiol. 2016; 6:188. PMID: 28066723.
      View in: PubMed
    16. Fujiwara T, Ye S, Castro-Gomes T, Winchell CG, Andrews NW, Voth DE, Varughese KI, Mackintosh SG, Feng Y, Pavlos N, Nakamura T, Manolagas SC, Zhao H. PLEKHM1/DEF8/RAB7 complex regulates lysosome positioning and bone homeostasis. JCI Insight. 2016 Oct 20; 1(17):e86330. PMID: 27777970.
      View in: PubMed
    17. Colonne PM, Winchell CG, Graham JG, Onyilagha FI, MacDonald LJ, Doeppler HR, Storz P, Kurten RC, Beare PA, Heinzen RA, Voth DE. Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages. PLoS Pathog. 2016 Oct; 12(10):e1005915. PMID: 27711191.
      View in: PubMed
    18. Colonne PM, Winchell CG, Voth DE. Hijacking Host Cell Highways: Manipulation of the Host Actin Cytoskeleton by Obligate Intracellular Bacterial Pathogens. Front Cell Infect Microbiol. 2016; 6:107. PMID: 27713866.
      View in: PubMed
    19. Graham JG, Winchell CG, Kurten RC, Voth DE. Development of an Ex Vivo Tissue Platform To Study the Human Lung Response to Coxiella burnetii. Infect Immun. 2016 05; 84(5):1438-1445. PMID: 26902725.
      View in: PubMed
    20. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, Albani D, Albert ML, Aldudo J, Alg?l H, Alirezaei M, Alloza I, Almasan A, Almonte-Beceril M, Alnemri ES, Alonso C, Altan-Bonnet N, Altieri DC, Alvarez S, Alvarez-Erviti L, Alves S, Amadoro G, Amano A, Amantini C, Ambrosio S, Amelio I, Amer AO, Amessou M, Amon A, An Z, Anania FA, Andersen SU, Andley UP, Andreadi CK, Andrieu-Abadie N, Anel A, Ann DK, Anoopkumar-Dukie S, Antonioli M, Aoki H, Apostolova N, Aquila S, Aquilano K, Araki K, Arama E, Aranda A, Araya J, Arcaro A, Arias E, Arimoto H, Ariosa AR, Armstrong JL, Arnould T, Arsov I, Asanuma K, Askanas V, Asselin E, Atarashi R, Atherton SS, Atkin JD, Attardi LD, Auberger P, Auburger G, Aurelian L, Autelli R, Avagliano L, Avantaggiati ML, Avrahami L, Awale S, Azad N, Bachetti T, Backer JM, Bae DH, Bae JS, Bae ON, Bae SH, Baehrecke EH, Baek SH, Baghdiguian S, Bagniewska-Zadworna A, Bai H, Bai J, Bai XY, Bailly Y, Balaji KN, Balduini W, Ballabio A, Balzan R, Banerjee R, B?nhegyi G, Bao H, Barbeau B, Barrachina MD, Barreiro E, Bartel B, Bartolom? A, Bassham DC, Bassi MT, Bast RC, Basu A, Batista MT, Batoko H, Battino M, Bauckman K, Baumgarner BL, Bayer KU, Beale R, Beaulieu JF, Beck GR, Becker C, Beckham JD, B?dard PA, Bednarski PJ, Begley TJ, Behl C, Behrends C, Behrens GM, Behrns KE, Bejarano E, Belaid A, Belleudi F, B?nard G, Berchem G, Bergamaschi D, Bergami M, Berkhout B, Berliocchi L, Bernard A, Bernard M, Bernassola F, Bertolotti A, Bess AS, Besteiro S, Bettuzzi S, Bhalla S, Bhattacharyya S, Bhutia SK, Biagosch C, Bianchi MW, Biard-Piechaczyk M, Billes V, Bincoletto C, Bingol B, Bird SW, Bitoun M, Bjedov I, Blackstone C, Blanc L, Blanco GA, Blomhoff HK, Boada-Romero E, B?ckler S, Boes M, Boesze-Battaglia K, Boise LH, Bolino A, Boman A, Bonaldo P, Bordi M, Bosch J, Botana LM, Botti J, Bou G, Bouch? M, Bouchecareilh M, Boucher MJ, Boulton ME, Bouret SG, Boya P, Boyer-Guittaut M, Bozhkov PV, Brady N, Braga VM, Brancolini C, Braus GH, Bravo-San Pedro JM, Brennan LA, Bresnick EH, Brest P, Bridges D, Bringer MA, Brini M, Brito GC, Brodin B, Brookes PS, Brown EJ, Brown K, Broxmeyer HE, Bruhat A, Brum PC, Brumell JH, Brunetti-Pierri N, Bryson-Richardson RJ, Buch S, Buchan AM, Budak H, Bulavin DV, Bultman SJ, Bultynck G, Bumbasirevic V, Burelle Y, Burke RE, Burmeister M, B?tikofer P, Caberlotto L, Cadwell K, Cahova M, Cai D, Cai J, Cai Q, Calatayud S, Camougrand N, Campanella M, Campbell GR, Campbell M, Campello S, Candau R, Caniggia I, Cantoni L, Cao L, Caplan AB, Caraglia M, Cardinali C, Cardoso SM, Carew JS, Carleton LA, Carlin CR, Carloni S, Carlsson SR, Carmona-Gutierrez D, Carneiro LA, Carnevali O, Carra S, Carrier A, Carroll B, Casas C, Casas J, Cassinelli G, Castets P, Castro-Obregon S, Cavallini G, Ceccherini I, Cecconi F, Cederbaum AI, Ce?a V, Cenci S, Cerella C, Cervia D, Cetrullo S, Chaachouay H, Chae HJ, Chagin AS, Chai CY, Chakrabarti G, Chamilos G, Chan EY, Chan MT, Chandra D, Chandra P, Chang CP, Chang RC, Chang TY, Chatham JC, Chatterjee S, Chauhan S, Che Y, Cheetham ME, Cheluvappa R, Chen CJ, Chen G, Chen GC, Chen G, Chen H, Chen JW, Chen JK, Chen M, Chen M, Chen P, Chen Q, Chen Q, Chen SD, Chen S, Chen SS, Chen W, Chen WJ, Chen WQ, Chen W, Chen X, Chen YH, Chen YG, Chen Y, Chen Y, Chen Y, Chen YJ, Chen YQ, Chen Y, Chen Z, Chen Z, Cheng A, Cheng CH, Cheng H, Cheong H, Cherry S, Chesney J, Cheung CH, Chevet E, Chi HC, Chi SG, Chiacchiera F, Chiang HL, Chiarelli R, Chiariello M, Chieppa M, Chin LS, Chiong M, Chiu GN, Cho DH, Cho SG, Cho WC, Cho YY, Cho YS, Choi AM, Choi EJ, Choi EK, Choi J, Choi ME, Choi SI, Chou TF, Chouaib S, Choubey D, Choubey V, Chow KC, Chowdhury K, Chu CT, Chuang TH, Chun T, Chung H, Chung T, Chung YL, Chwae YJ, Cianfanelli V, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy. 2016; 12(1):1-222. PMID: 26799652.
      View in: PubMed
    21. Winchell CG, Steele S, Kawula T, Voth DE. Dining in: intracellular bacterial pathogen interplay with autophagy. Curr Opin Microbiol. 2016 Feb; 29:9-14. PMID: 26462048.
      View in: PubMed
    22. Graham JG, Winchell CG, Sharma UM, Voth DE. Identification of ElpA, a Coxiella burnetii pathotype-specific Dot/Icm type IV secretion system substrate. Infect Immun. 2015 Mar; 83(3):1190-8. PMID: 25605765.
      View in: PubMed
    23. Larson CL, Beare PA, Voth DE, Howe D, Cockrell DC, Bastidas RJ, Valdivia RH, Heinzen RA. Coxiella burnetii effector proteins that localize to the parasitophorous vacuole membrane promote intracellular replication. Infect Immun. 2015 Feb; 83(2):661-70. PMID: 25422265.
      View in: PubMed
    24. Winchell CG, Graham JG, Kurten RC, Voth DE. Coxiella burnetii type IV secretion-dependent recruitment of macrophage autophagosomes. Infect Immun. 2014 Jun; 82(6):2229-38. PMID: 24643534.
      View in: PubMed
    25. Macdonald LJ, Graham JG, Kurten RC, Voth DE. Coxiella burnetii exploits host cAMP-dependent protein kinase signalling to promote macrophage survival. Cell Microbiol. 2014 Jan; 16(1):146-59. PMID: 24028560.
      View in: PubMed
    26. Stahl JA, Chavan SS, Sifford JM, MacLeod V, Voth DE, Edmondson RD, Forrest JC. Phosphoproteomic analyses reveal signaling pathways that facilitate lytic gammaherpesvirus replication. PLoS Pathog. 2013 Sep; 9(9):e1003583. PMID: 24068923.
      View in: PubMed
    27. Maturana P, Graham JG, Sharma UM, Voth DE. Refining the plasmid-encoded type IV secretion system substrate repertoire of Coxiella burnetii. J Bacteriol. 2013 Jul; 195(14):3269-76. PMID: 23687269.
      View in: PubMed
    28. Graham JG, MacDonald LJ, Hussain SK, Sharma UM, Kurten RC, Voth DE. Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages. Cell Microbiol. 2013 Jun; 15(6):1012-25. PMID: 23279051.
      View in: PubMed
    29. MacDonald LJ, Kurten RC, Voth DE. Coxiella burnetii alters cyclic AMP-dependent protein kinase signaling during growth in macrophages. Infect Immun. 2012 Jun; 80(6):1980-6. PMID: 22473604.
      View in: PubMed
    30. Voth DE, Broederdorf LJ, Graham JG. Bacterial Type IV secretion systems: versatile virulence machines. Future Microbiol. 2012 Feb; 7(2):241-57. PMID: 22324993.
      View in: PubMed
    31. Hussain SK, Voth DE. Coxiella subversion of intracellular host signaling. Adv Exp Med Biol. 2012; 984:131-40. PMID: 22711630.
      View in: PubMed
    32. Lockwood S, Voth DE, Brayton KA, Beare PA, Brown WC, Heinzen RA, Broschat SL. Identification of Anaplasma marginale type IV secretion system effector proteins. PLoS One. 2011; 6(11):e27724. PMID: 22140462.
      View in: PubMed
    33. Beare PA, Gilk SD, Larson CL, Hill J, Stead CM, Omsland A, Cockrell DC, Howe D, Voth DE, Heinzen RA. Dot/Icm type IVB secretion system requirements for Coxiella burnetii growth in human macrophages. mBio. 2011; 2(4):e00175-11. PMID: 21862628.
      View in: PubMed
    34. Voth DE. ThANKs for the repeat: Intracellular pathogens exploit a common eukaryotic domain. Cell Logist. 2011 Jul; 1(4):128-132. PMID: 22279611.
      View in: PubMed
    35. Broederdorf LJ, Voth DE. Cheating death: a coxiella effector prevents apoptosis. Front Microbiol. 2011; 2:43. PMID: 21747783.
      View in: PubMed
    36. Voth DE, Beare PA, Howe D, Sharma UM, Samoilis G, Cockrell DC, Omsland A, Heinzen RA. The Coxiella burnetii cryptic plasmid is enriched in genes encoding type IV secretion system substrates. J Bacteriol. 2011 Apr; 193(7):1493-503. PMID: 21216993.
      View in: PubMed
    37. Broederdorf, L. J., Kurten, R. C., Voth, D. E. Coxiella burnetii Alters cAMP-DependentProtein Kinase Signaling During Intracellular Growth in Macrophages. 2011.
    38. Hussain SK, Broederdorf LJ, Sharma UM, Voth DE. Host Kinase Activity is Required for Coxiella burnetii Parasitophorous Vacuole Formation. Front Microbiol. 2010; 1:137. PMID: 21772829.
      View in: PubMed
    39. Omsland A, Gilk SD, Shannon JG, Beare PA, Voth D, Howe D, Cockrell DC, Heinzen RA. Exploring the cause of human Q fever: recent advances in Coxiella burnetii research. Georgiev V. (Ed.): National Institute of Allergy and Infectious Diseases. 2010; Intramural Receasrch (Vol.3).
    40. Hussain, S. K., Broederdorf, L. J., Sharma, U. M., Voth, D. E. The Role of Host Kinase Signaling in Biogenesis of the Coxiella burnetii Parasitophorous Vacuole. 2010.
    41. Omsland, A., Gilk, S. D., Shannon, J. G., Beare, P. A., Voth, D. E., Howe, D., Cockrell, D. C., R. A. Heinzen. Exploring the cuase of human Q fever: recent advances in Coxiella burnetii research. In Georgiev, B. (Ed.): National Institute of Allergy and Infectious Diseases: Intramural Research (vol. 3), New York, Springer-Verlag. 2010; 3:75-86.
    42. Hussain, S. K., Sharma, U. M., Voth, D. E. The Role of Host Kinase Signaling in Biogenesis of the Coxiella Burnetii Parasitophorous Vacuole. 2010.
    43. Voth, D. E., Sharma, U. M., Hussain, S. K., L. J. Broederdorf. Cellular Microbiology of the Q Fever Agent, Coxiella Burnetii. 2010.
    44. Broederdorf, L. J., Voth, D. E. Host cAMP-Dependent Protein Kinase Activity is Required for Coxiella burnetii Parasitophorous Vacuole Formation. 2010.
    45. Voth DE, Howe D, Beare PA, Vogel JP, Unsworth N, Samuel JE, Heinzen RA. The Coxiella burnetii ankyrin repeat domain-containing protein family is heterogeneous, with C-terminal truncations that influence Dot/Icm-mediated secretion. J Bacteriol. 2009 Jul; 191(13):4232-42. PMID: 19411324.
      View in: PubMed
    46. Voth DE, Heinzen RA. Coxiella type IV secretion and cellular microbiology. Curr Opin Microbiol. 2009 Feb; 12(1):74-80. PMID: 19144560.
      View in: PubMed
    47. Gilk, S. D., Voth, D. E., R. A. Heinzen. Coxiella. (Review for Intracellular Niches of Pathogens - A Microbe's Guide Through the Host Cell). Wiley-VCH. 2009; 287-300.
    48. Voth D, Howe D, Beare PA, Vogel JP, Unsworth N, Samuel JE, RA Heinzen. The coxiella burnetti Ankyrin Repeat Domain Containing Protein Family is Heterogeneous, with C-Terminal Truncations That Influence Dot/Icm-Mediated Secretion. Journal of Bacteriology. 2009; 191:4232-4242.
    49. Gilk S.D., Voth, R.A. Heinzen. Coxiella. (Review for Intracellular Niches of Pathogens - A Microbe's Guide Through the Host Cell). Wiley-VCH. 2009; 287-300.
    50. Beare PA, Samuel JE, Omsland A, Voth D, Kupko J, Seshardi R, Massaka N, Unsworth N, William K, Sobral B, Porcella SF, RA Heinzen. Comparative Genomics Reveal Extensive Transposon-Mediated Genomic Plasticity and Diversuty Among Potential Effector Proteins Within the Genus Coxiella. Infection and Immunity. 2009; 77:642-656.
    51. Voth, D. E., Howe, D., Beare, P. A., Vogel, J. P., Unsworth, N., Samuel, J. E., R. A. Heinzen. The Coxiella burnetii Ankyrin Repeat Domain-Containing Protein Family is Heterogeneous, with C-Terminal Trunications That Influence Dot/Icm-Mediated Secretion. Journal of Bacteriology. 2009; (191):4232-4242.
    52. Beare PA, Unsworth N, Andoh M, Voth DE, Omsland A, Gilk SD, Williams KP, Sobral BW, Kupko JJ, Porcella SF, Samuel JE, Heinzen RA. Comparative genomics reveal extensive transposon-mediated genomic plasticity and diversity among potential effector proteins within the genus Coxiella. Infect Immun. 2009 Feb; 77(2):642-56. PMID: 19047403.
      View in: PubMed
    53. Voth DE, Heinzen RA. Sustained activation of Akt and Erk1/2 is required for Coxiella burnetii antiapoptotic activity. Infect Immun. 2009 Jan; 77(1):205-13. PMID: 18981248.
      View in: PubMed
    54. Voth, Howe D, Vogel JP, Unsworth N, Samuel JE, RA Heinzen. Dot/Icm-Dependent Translocation and Subcellular Localization of Coxiella burnetii Isolate-Specific Ankyrin Repeat Proteins. 2008.
    55. Voth, Howe D, Vogel JP, Unsworth N, Samuel JE, RA Heinzen. Functional Characterization of Coxiella burnetii Dot/Icm Substrates. 2008.
    56. Voth, D. E., Howe, D., Vogel, J. P., Unsworth, N., Samuel, J. E., R. A. Heinzen. Functional Characterization of Coxiella burnetii Dot/Icm Substrates. 2008.
    57. Voth, D. E., Howe, D., Vogel, J. P., Unsworth, N., Samuel, J. E., R. A. Heinzen. Dot/Icm-Dependent Translocation and Subcellular Localiztion of Coxiella Burnetii Isolate-Specific Ankyrin Repeat Proteins. 2008.
    58. Voth DE, Ballard JD. Critical intermediate steps in Clostridium sordellii lethal toxin-induced apoptosis. Biochem Biophys Res Commun. 2007 Nov 30; 363(4):959-64. PMID: 17910886.
      View in: PubMed
    59. Voth DE, Howe D, Heinzen RA. Coxiella burnetii inhibits apoptosis in human THP-1 cells and monkey primary alveolar macrophages. Infect Immun. 2007 Sep; 75(9):4263-71. PMID: 17606599.
      View in: PubMed
    60. Voth DE, Heinzen RA. Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii. Cell Microbiol. 2007 Apr; 9(4):829-40. PMID: 17381428.
      View in: PubMed
    61. Voth, Howe D, RA Heinzen. Coxiella burnetii Inhibits Apoptosis in Human THP-1 Cells and Primary Monkey Alveolar Macrophages. Infection and Immunity. 2007; 75:4263-4271.
    62. Voth, Howe D, RA Heinzen. Coxiella burnetii Inhibits Apoptosis and Modulates Cell Survival Signaling in Macrophages. 2007.
    63. Voth, Howe D, RA Heinzen. Coxiella burnetii Inhibits Intrinsic Apoptosis in Macrophages. 2007.
    64. Coleman SA, Fischer ER, Cockrell DC, Voth DE, Howe D, Mead DJ, Samuel JE, Heinzen RA. Proteome and antigen profiling of Coxiella burnetii developmental forms. Infect Immun. 2007 Jan; 75(1):290-8. PMID: 17088354.
      View in: PubMed
    65. Hamm EE, Voth DE, Ballard JD. Identification of Clostridium difficile toxin B cardiotoxicity using a zebrafish embryo model of intoxication. Proc Natl Acad Sci U S A. 2006 Sep 19; 103(38):14176-81. PMID: 16966605.
      View in: PubMed
    66. Salles II, Voth DE, Ward SC, Averette KM, Tweten RK, Bradley KA, Ballard JD. Cytotoxic activity of Bacillus anthracis protective antigen observed in a macrophage cell line overexpressing ANTXR1. Cell Microbiol. 2006 Aug; 8(8):1272-81. PMID: 16882031.
      View in: PubMed
    67. Voth DE, Martinez OV, Ballard JD. Variations in lethal toxin and cholesterol-dependent cytolysin production correspond to differences in cytotoxicity among strains of Clostridium sordellii. FEMS Microbiol Lett. 2006 Jun; 259(2):295-302. PMID: 16734793.
      View in: PubMed
    68. Voth DE, Hamm EE, Nguyen LG, Tucker AE, Salles II, Ortiz-Leduc W, Ballard JD. Bacillus anthracis oedema toxin as a cause of tissue necrosis and cell type-specific cytotoxicity. Cell Microbiol. 2005 Aug; 7(8):1139-49. PMID: 16008581.
      View in: PubMed
    69. Voth DE, Ballard JD. Clostridium difficile toxins: mechanism of action and role in disease. Clin Microbiol Rev. 2005 Apr; 18(2):247-63. PMID: 15831824.
      View in: PubMed
    70. Voth, Martinez OV, JD Ballard. Virulence Factor Profiles and Cell-Type Specificity of Cadaver-Derived Isolates of Clostridium sordellii. 2005.
    71. Voth, Martinez OV, JD Ballard. Virulence Factor Profiles of Cadaver-Derived Isolates of Clostridium sordellii. 2005.
    72. Hamm EE, Voth, JD Ballard. Cardiotoxicity of toxin B from Clostridium difficile. 2005.
    73. Voth DE, Qa'Dan M, Hamm EE, Pelfrey JM, Ballard JD. Clostridium sordellii lethal toxin is maintained in a multimeric protein complex. Infect Immun. 2004 Jun; 72(6):3366-72. PMID: 15155642.
      View in: PubMed
    74. Hamm EE, Voth, JD Ballard. The Developing Zebrafish Embryo as a Model for the Study of Intracellular Bacterial Toxins. 2004.
    75. Voth, Qa'Dan M, Hamm EE, Pelfrey JM, JD Ballard. Clostridium sordellii Lethal Toxin is Maintained ina Dissociable Protein Complex. 2004.
    76. Salles II, Tucker AE, Voth DE, Ballard JD. Toxin-induced resistance in Bacillus anthracis lethal toxin-treated macrophages. Proc Natl Acad Sci U S A. 2003 Oct 14; 100(21):12426-31. PMID: 14519843.
      View in: PubMed
    77. Tucker AE, Salles II, Voth DE, Ortiz-Leduc W, Wang H, Dozmorov I, Centola M, Ballard JD. Decreased glycogen synthase kinase 3-beta levels and related physiological changes in Bacillus anthracis lethal toxin-treated macrophages. Cell Microbiol. 2003 Aug; 5(8):523-32. PMID: 12864812.
      View in: PubMed
    78. Voth, Qa'Dan M, Hamm EE, Pelfrey JM, JD Ballard. Effects of pH on the Lethal Toxin of Clostridium sordellii. 2003.
    79. Voth, Qa'Dan M, Hamm EE, Pelfrey JM, JD Ballard. pH-Induced Activation of Clostridium sordellii Lethal Toxin. 2003.
    80. Voth, Qa'Dan M, Hamm EE, Pelfrey JM, JD Ballard. Effects of pH on the Lethal Toxin of Clostridium sordellii. 2003.
    81. Tucker AE, Salles II, Voth, Ortiz-Leduc W, Wang H, Dozmorov I, Centola M, JD Ballard. Decreased Glocogen Synthase Kinase 3-beta Levels and Related Physiological Changes in Bacillus anthracis Lethal Toxin-Treated Macrophages. Cellular Microbiology. 2003; 5:523-532.
    82. Voth, Ortiz-Leduc W, Tucker AE, Salles II, JD Ballard. Mechanisms of Anthrax Toxin-Induced Cell Death. 2002.
    83. Salles II, Tucker AE, Voth, JD Ballard. Adaptive Resistance to Anthrax Lethal Toxin. 2002.
    84. Tucker AE, Salles II, Ortiz-Leduc W, Voth, JD Ballard. DNA Array Profiles of Anthrax-Intoxicated Cells. 2002.
    85. Voth D. A Major Role for Host Phosphorylation Cascades in Biogenesis of the Coxiella burnetii Parasitophorous Vacuole.
    86. Hussain, S. K., Voth, D. E. Coxiella Subversion of Intracellular Host Signaling. (Review for upcoming Coxiella book).
    87. Voth, Howe D, Beare PA, Vogel JP, Unsworth N, Samuel JE, RA Heinzen. Coxiella burnetii Isolates Encode a Diverse Set of Ankyrin Repeat Domain-Containing Proteins that are Type IV Secretion System Substrates.
    88. Broederdorf, L. J., Voth, D. E. A Novel Apoptosis Prevention Strategy by Coxiella burnetii AnkG.
    Voth's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (239) concept(s)
    _
    Co-Authors Expand Description
    See all (9) people
    _
    Similar People Expand Description
    See all (40) people
    _
    Same Department Expand Description
    Search Department